Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

RASSF10 is an epigenetically silenced tumor suppressor in gastric cancer.

Li Z, Chang X, Dai D, Deng P, Sun Q.

Oncol Rep. 2014 Apr;31(4):1661-8. doi: 10.3892/or.2014.3039. Epub 2014 Feb 20.

PMID:
24573726
2.

RASSF10 is epigenetically silenced and functions as a tumor suppressor in gastric cancer.

Wei Z, Chen X, Chen J, Wang W, Xu X, Cai Q.

Biochem Biophys Res Commun. 2013 Mar 22;432(4):632-7. doi: 10.1016/j.bbrc.2013.02.033. Epub 2013 Feb 19.

PMID:
23428420
3.

Frequent epigenetic inactivation of RASSF10 in thyroid cancer.

Schagdarsurengin U, Richter AM, Wöhler C, Dammann RH.

Epigenetics. 2009 Nov 16;4(8):571-6. Epub 2009 Nov 14.

PMID:
19934646
4.

DNA methylation of NDRG2 in gastric cancer and its clinical significance.

Chang X, Li Z, Ma J, Deng P, Zhang S, Zhi Y, Chen J, Dai D.

Dig Dis Sci. 2013 Mar;58(3):715-23. doi: 10.1007/s10620-012-2393-z. Epub 2012 Sep 26.

PMID:
23010743
5.

RASSF10 is epigenetically inactivated and induces apoptosis in lung cancer cell lines.

Wang Y, Ma T, Bi J, Song B, Zhou Y, Zhang C, Gao M.

Biomed Pharmacother. 2014 Apr;68(3):321-6. doi: 10.1016/j.biopha.2013.12.005. Epub 2013 Dec 21. Erratum in: Biomed Pharmacother. 2014 Oct;68(8):1177.

PMID:
24433832
6.

Epigenetic down regulation of RASSF10 and its possible clinical implication in prostate carcinoma.

Dansranjavin T, Wagenlehner F, Gattenloehner S, Steger K, Weidner W, Dammann R, Schagdarsurengin U.

Prostate. 2012 Oct 1;72(14):1550-8. doi: 10.1002/pros.22510. Epub 2012 Mar 13.

PMID:
22415519
7.

Hypermethylation and clinicopathological significance of RASAL1 gene in gastric cancer.

Chen H, Pan Y, Cheng ZY, Wang Z, Liu Y, Zhao ZJ, Fan H.

Asian Pac J Cancer Prev. 2013;14(11):6261-5.

8.

Epigenetic inactivation of the RASSF10 candidate tumor suppressor gene is a frequent and an early event in gliomagenesis.

Hill VK, Underhill-Day N, Krex D, Robel K, Sangan CB, Summersgill HR, Morris M, Gentle D, Chalmers AD, Maher ER, Latif F.

Oncogene. 2011 Feb 24;30(8):978-89. doi: 10.1038/onc.2010.471. Epub 2010 Oct 18.

PMID:
20956940
9.

RASSF10 promoter hypermethylation is frequent in malignant melanoma of the skin but uncommon in nevus cell nevi.

Helmbold P, Richter AM, Walesch S, Skorokhod A, Marsch WCh, Enk A, Dammann RH.

J Invest Dermatol. 2012 Mar;132(3 Pt 1):687-94. doi: 10.1038/jid.2011.380. Epub 2011 Nov 24.

10.

The Pleckstrin and Sec7 domain-containing gene as a novel epigenetic modification marker in human gastric cancer and its clinical significance.

Zhu X, Liu J, Xu X, Zhang C, Dai D.

Int J Oncol. 2015 Jan;46(1):195-204. doi: 10.3892/ijo.2014.2736. Epub 2014 Oct 30.

PMID:
25355626
11.

The novel RASSF6 and RASSF10 candidate tumour suppressor genes are frequently epigenetically inactivated in childhood leukaemias.

Hesson LB, Dunwell TL, Cooper WN, Catchpoole D, Brini AT, Chiaramonte R, Griffiths M, Chalmers AD, Maher ER, Latif F.

Mol Cancer. 2009 Jul 1;8:42. doi: 10.1186/1476-4598-8-42.

12.

Epigenetic silencing of RASSF10 promotes tumor growth in esophageal squamous cell carcinoma.

Lu D, Ma J, Zhan Q, Li Y, Qin J, Guo M.

Discov Med. 2014 Apr;17(94):169-78.

13.

Identification of genes epigenetically silenced by CpG methylation in human gastric carcinoma.

Jee CD, Kim MA, Jung EJ, Kim J, Kim WH.

Eur J Cancer. 2009 May;45(7):1282-93. doi: 10.1016/j.ejca.2008.12.027. Epub 2009 Feb 3.

PMID:
19195878
14.

Gene methylation in gastric cancer.

Qu Y, Dang S, Hou P.

Clin Chim Acta. 2013 Sep 23;424:53-65. doi: 10.1016/j.cca.2013.05.002. Epub 2013 May 10. Review.

15.

Epigenetic alteration of CCDC67 and its tumor suppressor function in gastric cancer.

Park SJ, Jang HR, Kim M, Kim JH, Kwon OH, Park JL, Noh SM, Song KS, Kim SY, Kim YH, Kim YS.

Carcinogenesis. 2012 Aug;33(8):1494-501. doi: 10.1093/carcin/bgs178. Epub 2012 May 18.

16.

N-terminal RASSF family: RASSF7-RASSF10.

Underhill-Day N, Hill V, Latif F.

Epigenetics. 2011 Mar;6(3):284-92. Epub 2011 Mar 1. Review.

17.

The tumor suppressor RASSF10 is upregulated upon contact inhibition and frequently epigenetically silenced in cancer.

Richter AM, Walesch SK, Würl P, Taubert H, Dammann RH.

Oncogenesis. 2012 Jun 25;1:e18. doi: 10.1038/oncsis.2012.18.

18.

The RASSF gene family members RASSF5, RASSF6 and RASSF7 show frequent DNA methylation in neuroblastoma.

Djos A, Martinsson T, Kogner P, Carén H.

Mol Cancer. 2012 Jun 13;11:40. doi: 10.1186/1476-4598-11-40.

19.

Aberrant gene methylation in the lymph nodes provides a possible marker for diagnosing micrometastasis in gastric cancer.

Hiraki M, Kitajima Y, Sato S, Mitsuno M, Koga Y, Nakamura J, Hashiguchi K, Noshiro H, Miyazaki K.

Ann Surg Oncol. 2010 Apr;17(4):1177-86. doi: 10.1245/s10434-009-0815-8. Epub 2009 Dec 3.

PMID:
19957042
20.

Frequent silencing of popeye domain-containing genes, BVES and POPDC3, is associated with promoter hypermethylation in gastric cancer.

Kim M, Jang HR, Haam K, Kang TW, Kim JH, Kim SY, Noh SM, Song KS, Cho JS, Jeong HY, Kim JC, Yoo HS, Kim YS.

Carcinogenesis. 2010 Sep;31(9):1685-93. doi: 10.1093/carcin/bgq144. Epub 2010 Jul 12.

Items per page

Supplemental Content

Write to the Help Desk